<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27139612</article-id>
      <article-id pub-id-type="pmc">4855059</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2016.36.4.371</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
          <subj-group subj-group-type="subheading">
            <subject>Diagnostic Hematology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Novel <italic>KIT</italic> INDEL Mutation in Acute Myeloid Leukemia With t(8;21)(q22;q22); <italic>RUNX1-RUNX1T1</italic></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Jun Hyung</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Chungoo</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Soo-Hyun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Shin</surname>
            <given-names>Myung-Geun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Laboratory Medicine, Chonnam National University Medical School and Chonnam National University Hwasun Hospital, Hwasun, Korea.</aff>
      <aff id="A2"><label>2</label>School of Biological Sciences and Technology, Chonnam National University, Gwangju, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Myung-Geun Shin. Department of Laboratory Medicine, Chonnam National University Medical School and Chonnam National University Hwasun Hospital, 322 Seoyang-ro, Hwasun-eup, Hwasun-gun, Jeollanam-do 58128, Korea. Tel: +82-61-379-7950, Fax: +82-61-379-7984, <email>mgshin@chonnam.ac.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <volume>36</volume>
      <issue>4</issue>
      <fpage>371</fpage>
      <lpage>374</lpage>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>12</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>16</day>
          <month>2</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>3</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <funding-group>
        <award-group>
          <funding-source country="KR">
            <institution-wrap>
              <institution>National Research Foundation of Korea</institution>
              <institution-id institution-id-type="CrossRef">http://dx.doi.org/10.13039/501100003725</institution-id>
            </institution-wrap>
          </funding-source>
          <award-id>2011-0030034</award-id>
        </award-group>
        <award-group>
          <funding-source country="KR">
            <institution-wrap>
              <institution>Ministry of Health and Welfare</institution>
              <institution-id institution-id-type="CrossRef">http://dx.doi.org/10.13039/501100003625</institution-id>
            </institution-wrap>
          </funding-source>
          <award-id>2013-1320070</award-id>
        </award-group>
        <award-group>
          <funding-source country="KR">
            <institution-wrap>
              <institution>Ministry of Environment</institution>
              <institution-id institution-id-type="CrossRef">http://dx.doi.org/10.13039/501100003562</institution-id>
            </institution-wrap>
          </funding-source>
        </award-group>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>KIT (also known as c-KIT) is a receptor tyrosine kinase expressed on various cell types [<xref rid="B1" ref-type="bibr">1</xref>]. <italic>KIT</italic> mutations are detected in approximately 5% of patients newly diagnosed with acute myeloid leukemia (AML) and in 20-30% of patients with core-binding factor AML [<xref rid="B2" ref-type="bibr">2</xref><xref rid="B3" ref-type="bibr">3</xref>]. <italic>KIT</italic> mutations are predominantly presented as one or two amino acid substitutions affecting codon 816. The most frequent mutation type, D816V, is detected in about 40% of cases with AML, where <italic>KIT</italic> is mutated [<xref rid="B4" ref-type="bibr">4</xref>]. In AML with t(8;21), the presence of <italic>KIT</italic> mutation at codon 816 is associated with a high white blood cell (WBC) count at diagnosis, a high incidence of extramedullary leukemia, and high risk of relapse during the course of the disease [<xref rid="B5" ref-type="bibr">5</xref>]. Other less frequent types of <italic>KIT</italic> mutation are D816Y, D816H, and D816I. <italic>KIT</italic> mutations present a prognostic significance. The National Comprehensive Cancer Network categorized AML with either t(8;21) or inv(16)/t(16;16) combined with <italic>KIT</italic> mutations as the intermediate-risk group [<xref rid="B6" ref-type="bibr">6</xref>]. We report a novel INDEL mutation in KIT codon 816, discovered in a woman with AML with t(8;21)(q22;q22); <italic>RUNX1-RUNX1T1</italic>.</p>
    <p>A 35-yr-old woman was admitted for purpura in both lower limbs. The initial complete blood cell count indicated: WBC count, 20.1&#xD7;10<sup>9</sup>/L; hemoglobin, 8.2 g/dL; and platelet count, 15&#xD7;10<sup>9</sup>/L. A peripheral blood smear revealed leukocytosis with 45% of blasts. The bone marrow (BM) aspirate smear and cytochemical stains showed an increased number of myeloblasts (68%) and other myeloid precursors (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). The 197 bp-sized transcript of <italic>RUNX1</italic> exon 6/<italic>RUNX1T1</italic> exon 2 was detected in a multiplex PCR analysis of BM aspirates. In the cytogenetic study, the karyotype was 46,XX,t(8;21)(q22;q22)[18]/46,XX[2]. The patient was diagnosed with AML with t(8;21)(q22;q22); <italic>RUNX1-RUNX1T1</italic>. In the screening test for <italic>KIT</italic> mutations using a real-time allele-specific PCR kit (Real-Q C-KIT; BioSewoom, Seoul, Korea), a mutation was detected, which was not the D816V, D816Y, or D816H type (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). Conventional sequencing was performed to identify the mutation. Unlike the common mutation types presenting one or two ambiguous bases in codon 816, the sequencing result showed five consecutive ambiguous bases through codon 815&#x2013;817 (<xref ref-type="fig" rid="F1">Fig. 1C</xref>). Allele separation by T-vector cloning using pGEM-T Easy Vector Systems (Promega, Madison, WI, USA) and additional conventional sequencing were performed and a missense INDEL mutation NM_000222.2:c.2445_2449delAGACAinsGTTAC (p.D816_I817delinsLL) was confirmed. To the best of our knowledge, this mutation has not yet been reported.</p>
    <p>Three <italic>in-silico</italic> prediction tools were utilized to predict the effect of the mutation on the KIT protein function and stability (<xref ref-type="table" rid="T1">Table 1</xref>). Using SIFT (Sorting Tolerant From Intolerant, version 1.03, <ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org/">http://sift.jcvi.org/</ext-link>; J. Craig Venter Institute, La Jolla, CA, USA) [<xref rid="B7" ref-type="bibr">7</xref>], exploiting the degree of conservation of amino acid residues derived from functionally related protein sequences, D816L, I817L, and D816V mutations were predicted to be 'damaging', with a SIFT score equal to 0 (the amino acid substitution is predicted as 'damaging' if the score is &#x2264;0.05). Using PolyPhen-2 (Polymorphism Phenotyping v2, version 2.2.2, <ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>; Division of Genetics, Brigham &amp; Women's Hospital, Harvard Medical School, Boston, MA, USA) [<xref rid="B8" ref-type="bibr">8</xref>] to predict the possible impact of an amino acid substitution on the structure and function of a protein using several features, including sequences, phylogenetic, and structural information, D816L and I817L were predicted to be 'probably damaging' with a score of 1.000, and 'possibly damaging' with a score of 0.955, respectively. By comparison, the D816V mutation was predicted to be 'probably damaging', with a score of 0.999. Using SABLE (Accurate prediction of Solvent AccessiBiLitiEs, version 2, <ext-link ext-link-type="uri" xlink:href="http://sable.cchmc.org/">http://sable.cchmc.org/</ext-link>; Division of Biomedical Informatics, Children's Hospital Research Foundation, Cincinnati, OH, USA) [<xref rid="B9" ref-type="bibr">9</xref>], which predicts the relative solvent accessibility of amino acid residues and secondary structures in proteins using evolutionary profiles, the D816_I817delinsLL mutation was predicted to present physicochemical properties similar to those of D816V when compared with both the wild-type and the D816V mutation (<xref ref-type="fig" rid="F1">Fig. 1D</xref>). In the physicochemical property prediction, both D816V and D816_I817delinsLL were predicted to be hydrophobic, whereas the wild type D816 and I817 were predicted to be negatively charged and hydrophobic, respectively. Considering these <italic>in-silico</italic> prediction results, we concluded that the clinical significance of D816_I817delinsLL mutation would be similar to that of the pathogenic D816V mutation.</p>
    <p>In the follow-up BM examination, one month after the induction chemotherapy using idarubicin and cytarabine, the BM aspirate smear showed 14% of myeloblasts and the response was determined as resistant disease [<xref rid="B10" ref-type="bibr">10</xref>]. In the next follow-up BM examination, one month after re-induction chemotherapy using daunorubicin and cytarabine, 3% of myeloblasts were observed on the BM aspirate smear, and the patient was diagnosed with a morphological leukemia-free state.</p>
    <p>This is the first report on a novel <italic>KIT</italic> INDEL mutation in exon 17, D816_I817delinsLL.</p>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>This study was supported by the Leading Foreign Research Institute Recruitment Program (No. 2011-0030034) through the NRF funded by the Ministry of Education, Science and Technology (MEST), a grant from the National R&amp;D Program for Cancer Control, Ministry of Health &amp; Welfare, Republic of Korea (No. 2013-1320070) and grants from the Environmental Health Center funded by the Ministry of Environment, Republic of Korea.</p>
    </ack>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Authors' Disclosures of Potential Conflicts of Interest:</bold> No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <name>
              <surname>Lovly</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sosman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pao</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <source>KIT. My cancer genome</source>
          <date-in-citation content-type="updated">Updated on Jun 16, 2015</date-in-citation>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/?tab=0">http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/?tab=0</ext-link>
          </comment>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patel</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>G&#xF6;nen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Figueroa</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Fernandez</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Racevskis</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prognostic relevance of integrated genetic profiling in acute myeloid leukemia</article-title>
          <source>N Engl J Med</source>
          <year>2012</year>
          <volume>366</volume>
          <fpage>1079</fpage>
          <lpage>1089</lpage>
          <pub-id pub-id-type="pmid">22417203</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D&#xF6;hner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Weisdorf</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Bloomfield</surname>
              <given-names>CD</given-names>
            </name>
          </person-group>
          <article-title>Acute Myeloid Leukemia</article-title>
          <source>N Engl J Med</source>
          <year>2015</year>
          <volume>373</volume>
          <fpage>1136</fpage>
          <lpage>1152</lpage>
          <pub-id pub-id-type="pmid">26376137</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <name>
              <surname>Wheeler</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Seegmiller</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vnencak-Jones</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <source>KIT c.2447A&gt;T (D816V) mutation in acute myeloid leukemia</source>
          <date-in-citation content-type="updated">Updated on Sep 9, 2013</date-in-citation>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275/">http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275/</ext-link>
          </comment>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cairoli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Beghini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Grillo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nadali</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Elice</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ripamonti</surname>
              <given-names>CB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study</article-title>
          <source>Blood</source>
          <year>2006</year>
          <volume>107</volume>
          <fpage>3463</fpage>
          <lpage>3468</lpage>
          <pub-id pub-id-type="pmid">16384925</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="webpage">
          <collab>National Comprehensive Cancer Network</collab>
          <source>Acute Myeloid Leukemia (Version 1.2015)</source>
          <date-in-citation content-type="updated">Updated on Dec 3, 2014</date-in-citation>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="http://www.nccn.org/professionals/physician_gls/pdf/aml.pdf">http://www.nccn.org/professionals/physician_gls/pdf/aml.pdf</ext-link>
          </comment>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kumar</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Henikoff</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <article-title>Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm</article-title>
          <source>Nat Protoc</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>1073</fpage>
          <lpage>1081</lpage>
          <pub-id pub-id-type="pmid">19561590</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adzhubei</surname>
              <given-names>IA</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Peshkin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ramensky</surname>
              <given-names>VE</given-names>
            </name>
            <name>
              <surname>Gerasimova</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bork</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A method and server for predicting damaging missense mutations</article-title>
          <source>Nat Methods</source>
          <year>2010</year>
          <volume>7</volume>
          <fpage>248</fpage>
          <lpage>249</lpage>
          <pub-id pub-id-type="pmid">20354512</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adamczak</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Porollo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Meller</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Accurate prediction of solvent accessibility using neural networks-based regression</article-title>
          <source>Proteins</source>
          <year>2004</year>
          <volume>56</volume>
          <fpage>753</fpage>
          <lpage>767</lpage>
          <pub-id pub-id-type="pmid">15281128</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheson</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Kopecky</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>B&#xFC;chner</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Willman</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Estey</surname>
              <given-names>EH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia</article-title>
          <source>J Clin Oncol</source>
          <year>2003</year>
          <volume>21</volume>
          <fpage>4642</fpage>
          <lpage>4649</lpage>
          <pub-id pub-id-type="pmid">14673054</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <title>(A) Bone marrow aspirate smear showing blasts presenting an abundant granular cytoplasm with perinuclear clearing, large orange-pink granules, and distinct Auer rods (Wright-Giemsa stain, &#xD7;1,000). (B) Result of real-time allele-specific PCR for <italic>KIT</italic> mutation (Real-Q C-KIT). The amplification curve of the patient sample (threshold cycle [C<sub>t</sub>]: 29.4) and the amplification curve of positive control (C<sub>t</sub>: 26.1) for <italic>KIT</italic> mutation screening are presented as the green and red line, respectively. The other amplification curves for <italic>KIT</italic> mutation genotyping such as D816V, D816Y, and D816H are not shown (not amplified). Rn is the normalized fluorescence signal of the reporter dye and &#x394;Rn is Rn minus the baseline. The threshold of &#x394;Rn is 0.1 and the cutoff value for <italic>KIT</italic> mutation positive is less than or equal to 38 as Ct. (C) Results of sequencing analysis of codon 815&#x2013;817 of the <italic>KIT</italic>. The original sequence of the patient is presented (upper sequence) as well as the sequence of the wild-type allele after allele separation (middle sequence) and the sequence of the mutant allele after allele-separation (lower sequence). (D) Results of the <italic>in-silico</italic> prediction of protein structure and characteristics by SABLE. Wild-type (upper structure); D816V mutation (middle structure); D816_I817delinsLL mutation (lower structure). The highlighted background (blue) represents hydrophobic amino acids. The detail properties are explained in the POLYVIEW-2D documentation (<ext-link ext-link-type="uri" xlink:href="http://polyview.cchmc.org/polyview_doc.html">http://polyview.cchmc.org/polyview_doc.html</ext-link>).</title>
      </caption>
      <graphic xlink:href="alm-36-371-g001"/>
    </fig>
    <table-wrap id="T1" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <title>Results of <italic>in-silico</italic> predictions about mutations in codon 816 and 817 of the <italic>KIT</italic></title>
      </caption>
      <alternatives>
        <graphic xlink:href="alm-36-371-i001"/>
        <table frame="hsides" rules="rows">
          <col width="9.25%" span="1"/>
          <col width="20.26%" span="1"/>
          <col width="9.25%" span="1"/>
          <col width="9.25%" span="1"/>
          <col width="14.54%" span="1"/>
          <col width="9.25%" span="1"/>
          <col width="13.22%" span="1"/>
          <col width="14.98%" span="1"/>
          <thead>
            <tr>
              <th valign="middle" align="left" rowspan="2" colspan="1" style="background-color:rgb(218,227,244)">Tools</th>
              <th valign="middle" align="center" rowspan="2" colspan="1" style="background-color:rgb(218,227,244)"/>
              <th valign="top" align="center" rowspan="1" colspan="2" style="background-color:rgb(218,227,244)">Wild-type</th>
              <th valign="top" align="center" rowspan="1" colspan="2" style="background-color:rgb(218,227,244)">D816V</th>
              <th valign="top" align="center" rowspan="1" colspan="2" style="background-color:rgb(218,227,244)">D816_I817delinsLL</th>
            </tr>
            <tr>
              <th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)">D816</th>
              <th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)">I817</th>
              <th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)">D816V</th>
              <th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)">I817</th>
              <th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)">D816L</th>
              <th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(218,227,244)">I817L</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">SIFT</td>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">-</td>
              <td valign="top" align="center" rowspan="1" colspan="1">-</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Damaging (Score 0<sup>*</sup>)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">-</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Damaging (Score 0)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Damaging (Score 0)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">PolyPhen-2</td>
              <td valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)"/>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">-</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">-</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Probably damaging (Score 0.999<sup>&#x2020;</sup>)</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">-</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Probably damaging (Score 1.000)</td>
              <td valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(238,242,249)">Possibly damaging (Score 0.955)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="3" colspan="1">SABLE</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Protein structure<sup>&#x2021;</sup></td>
              <td valign="top" align="center" rowspan="1" colspan="1">H</td>
              <td valign="top" align="center" rowspan="1" colspan="1">C</td>
              <td valign="top" align="center" rowspan="1" colspan="1">H</td>
              <td valign="top" align="center" rowspan="1" colspan="1">C</td>
              <td valign="top" align="center" rowspan="1" colspan="1">H</td>
              <td valign="top" align="center" rowspan="1" colspan="1">C</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Relative solvent accessibility<sup>&#xA7;</sup></td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Physicochemical properties<sup>&#x2225;</sup></td>
              <td valign="top" align="center" rowspan="1" colspan="1">N</td>
              <td valign="top" align="center" rowspan="1" colspan="1">H</td>
              <td valign="top" align="center" rowspan="1" colspan="1">H</td>
              <td valign="top" align="center" rowspan="1" colspan="1">H</td>
              <td valign="top" align="center" rowspan="1" colspan="1">H</td>
              <td valign="top" align="center" rowspan="1" colspan="1">H</td>
            </tr>
          </tbody>
        </table>
      </alternatives>
      <table-wrap-foot>
        <fn>
          <p><sup>*</sup>SIFT score: the amino acid substitution is predicted to be damaging when the score is &#x2264;0.05, and tolerated when the score is &gt;0.05; <sup>&#x2020;</sup>PolyPhen-2 score is the probability of the substitution being damaging; <sup>&#x2021;</sup>SABLE Protein structure: H (helix), E (beta strand), C (coil); <sup>&#xA7;</sup>SABLE Relative solvent accessibility: level of exposure (0-completely buried, 9-fully exposed); <sup>&#x2225;</sup>SABLE Physicochemical properties: H-hydrophobic, N-negatively charged.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
